Spots

IPO postponements are accelerating in third quarter, even beyond Oura

Biometric ring maker Oura delayed its IPO on Tuesday, citing "uncertainty" in market conditions.

Oura faced specific concerns about a concentrated product

Oura faced specific concerns about a concentrated product line. But, more broadly, IPO postponements and withdrawals are becoming more common. Macroeconomic factors and more private market alternatives may be dampening activity.

Biometric ring maker Oura raised eyebrows on Wall

Biometric ring maker Oura raised eyebrows on Wall Street Tuesday, postponing its initial public offering due to "uncertainty" in market conditions while also claiming there was "strong demand" for stock.

IPO delays have accelerated in 2026, even as

IPO delays have accelerated in 2026, even as Oura faced some company-specific pushback from the Street. Market conditions for new offerings are suddenly becoming a headwind for companies thinking about going public now, largely because of surging bonds yields, analysts say.

"The fact that we've had three or four

"The fact that we've had three or four in a row – a string of postponements – I think that does tell you something about the market," Matthew Kennedy, senior strategist at IPO specialist Renaissance Capital, told CNBC. "You can't really point to all four of them and say it's company-specific issues."

Four companies in different sectors, all aiming to

Four companies in different sectors, all aiming to raise at least $50 million, announced postponements or pulled their IPOs altogether in the past week, according to Renaissance Capital data. That makes seven in the third quarter, up from four in the second quarter and three in the first.

Before Oura's postponement on Tuesday, nuclear power component

Before Oura's postponement on Tuesday, nuclear power component maker Holtec Nuclear withdrew its IPO last Friday; materials company Amaero postponed its IPO last Wednesday; and Bamboo Insurance postponed its IPO on Sept. 22.

"I've got a little bit of sympathy for

"I've got a little bit of sympathy for market conditions as a rationale," said Jay Ritter, director of the IPO Initiative at the University of Florida's Warrington College of Business. "The fact that three prominent companies are doing this does indicate that it's not company-specific."

It's been a solid year for IPOs, with

It's been a solid year for IPOs, with about $146.9 billion in proceeds coming in 110 deals, excluding special purpose acquisition companies, Renaissance Capital data shows. Those figures include mega offerings from SpaceX and South Korean memory maker SK Hynix in the second quarter.

Still, that's down 30% from this time last

Still, that's down 30% from this time last year. In all of 2025 there were 202 IPOs, the most since 2021 when there were close to 400. Total proceeds are up 394% this year, largely due to the SpaceX, SK Hynix and Cerebras offerings.

News

IPO postponements are accelerating in third quarter, even beyond Oura

Biometric ring maker Oura delayed its IPO on Tuesday, citing "uncertainty" in market conditions.

@spots #finance #markets
Source: CNBC
See more like this